744 results on '"Liao, Ronglih"'
Search Results
2. Signal intensity coefficient as a detector of aortic stenosis-induced myocardial fibrosis and its correlation to the long term outcome
3. Abstract 15041: Single-Cell RNA Sequencing Reveals Four Distinctive Endothelial Subpopulations Through Mouse Endothelial Aging
4. Abstract 11641: The Role of Inflammation in a Humanized Mouse Model of Transthyretin Cardiac Amyloidosis
5. Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
6. Proteotoxicity and Autophagy in Neurodegenerative and Cardiovascular Diseases
7. Functional Capacity in Light Chain Amyloid Cardiomyopathy: Prognostic Value and Changes With Therapy
8. Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration
9. Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure.
10. Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy
11. Correction: A single combination gene therapy treats multiple age-related diseases
12. A single combination gene therapy treats multiple age-related diseases
13. Abstract 15594: Decreasing the High Risk of Ponatinib-Induced Cardiovascular Toxicity in Chronic Myeloid Leukemia
14. MicroRNA-21 regulates right ventricular remodeling secondary to pulmonary arterial pressure overload
15. Proteotoxicity and Autophagy in Neurodegenerative and Cardiovascular Diseases
16. Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics.
17. Angiotensin II blockers improve cardiac coronary flow under hemodynamic pressure overload
18. Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis.
19. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
20. Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation
21. Quantification of Right Ventricular Amyloid Burden with 18F-florbetapir PET/CT and its Association with Right Ventricular Dysfunction and Outcomes in Light-Chain Amyloidosis
22. Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation
23. Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity
24. Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis
25. Reduction of Cardiac AL Amyloid Burden on Serial 18F-Florbetapir PET/CT - a Comparison to Cardiac MRI and NT-proBNP
26. Alteration in ventricular pressure stimulates cardiac repair and remodeling
27. Hydrogels for cardiac tissue engineering
28. Microfluidics-Assisted Fabrication of Gelatin-Silica Core–Shell Microgels for Injectable Tissue Constructs
29. Myocardial Characterization for Early Diagnosis, Treatment Response Monitoring, and Risk Assessment in Systemic Light-Chain Amyloidosis
30. Prognostic Value of Left Ventricular 18F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis
31. MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling.
32. Calcium and Heart Disease
33. Elucidating effects of the environmental pollutant benzo[a]pyrene [BaP] on cardiac arrhythmogenicity
34. Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo
35. Mitochondrial MUL1 E3 ubiquitin ligase regulates Hypoxia Inducible Factor (HIF-1α) and metabolic reprogramming by modulating the UBXN7 cofactor protein
36. Harnessing Cardiac Regeneration as a Potential Therapeutic Strategy for AL Cardiac Amyloidosis
37. Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
38. Supplementary Figure from Reengineering Ponatinib to Minimize Cardiovascular Toxicity
39. L-2-Hydroxyglutarate Protects Against Cardiac Injury via Metabolic Remodeling
40. Cardiac Stem and Progenitor Cells
41. Regenerative therapy for cardiovascular disease
42. Abstract 17099: Mortality From Heart Failure and Dementia in the United States: Centers for Disease Control (CDC) WONDER 1999 to 2015
43. Large and Small Animal Models of Heart Failure With Reduced Ejection Fraction
44. Reengineering Ponatinib to Minimize Cardiovascular Toxicity
45. Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease
46. Regeneration in heart disease—Is ECM the key?
47. RESTING MYOCARDIAL BLOOD FLOW IS INVERSELY RELATED TO AMYLOID BURDEN IN LIGHT CHAIN CARDIAC AMYLOIDOSIS
48. SERUM BIOMARKERS AND AMYLOID BURDEN BY LEFT VENTRICULAR EXTRACELLULAR VOLUME PREDICT ADVERSE OUTCOMES IN LIGHT CHAIN AMYLOIDOSIS
49. Contributors
50. Cell Therapy for Cardiac Regeneration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.